According to a recent LinkedIn post from ABM Respiratory Care, the company plans to exhibit its BiWaze Clear and BiWaze Cough airway-clearance systems at the upcoming Medtrade 2026 conference in Phoenix. The post indicates that the solutions are positioned for both hospital and home care settings, and invites attendees to visit booth #621 or schedule product demonstrations.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests ABM Respiratory Care is targeting the home medical equipment and durable medical equipment channels, as reflected in the conference focus and referenced hashtags. For investors, increased visibility at Medtrade could support lead generation, broaden distribution relationships, and strengthen the company’s positioning in the respiratory care market, potentially contributing to future revenue growth if interest converts to commercial adoption.
By emphasizing simplified airway-clearance therapy across care settings, the LinkedIn content implies a strategy to address both acute and chronic care use cases. This dual-market focus may help diversify ABM Respiratory Care’s customer base, reduce dependence on any single segment, and enhance its competitive stance against other respiratory device providers active in hospital and home environments.